Myval Transcatheter Heart Valve System in the Treatment of Severe Symptomatic Aortic Stenosis

References

• Wenaweser P , PrazF, StorteckyS. Transcatheter aortic valve implantation today and tomorrow. Swiss Med. Wkly, 146(1112), 1149–1161 (2016).
   Google Scholar
• Varadarajan P , KapoorN, BansalRC, PaiRG. Survival in elderly patients with severe aortic stenosis is dramatically improved by aortic valve replacement: results from a cohort of 277 patients aged > or =80 years. Eur. J. Cardiothorac. Surg., 30(5), 722–727 (2006).
   PubMed Web of Science ®Google Scholar
• Moore M , ChenJ, MallowPJ, RizzoJA. The direct health-care burden of valvular heart disease: evidence from US national survey data. Clinicoecon. Outcomes Res., 8, 613–627 (2016).
   PubMedGoogle Scholar
• Thoenes M , BramlageP, ZamoranoPet al. Patient screening for early detection of aortic stenosis (AS)-review of current practice and future perspectives. J. Thorac. Dis., 10(9), 5584–5594 (2018).
   PubMed Web of Science ®Google Scholar
• Gupta P , AroraS, QamarA, GuptaM, SethA. Current status of transcatheter aortic valve replacement in India. Cardiovasc. Diagn. Ther., 10(1), 83–88 (2019).
   Web of Science ®Google Scholar
• Nishimura RA , OttoCM, BonowROet al. 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 129(23), 2440–2492 (2014).
   PubMed Web of Science ®Google Scholar
• Arora S , MisenheimerJA, RamarajR. Transcatheter aortic valve replacement: comprehensive review and present status. Tex. Heart Inst. J., 44(1), 29–38 (2017).
   PubMed Web of Science ®Google Scholar
• Abdelgawad AME , HusseinMA, NaeimH, AbuelattaR, AlghamdyS. A comparative study of TAVR versus SAVR in moderate and high-risk surgical patients: hospital outcome and midterm results. Heart Surg. Forum, 22(5), E331–E339 (2019).
   PubMed Web of Science ®Google Scholar
• Leon MB , SmithCR, MackMJet al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N. Engl. J. Med., 374(17), 1609–1620 (2016).
   PubMed Web of Science ®Google Scholar
• Reardon MJ , KleimanNS, AdamsDHet al. Outcomes in the randomized CoreValve US pivotal high risk trial in patients with a society of thoracic surgeons risk score of 7% or less. JAMA Cardiol., 1(8), 945–949 (2016).
   PubMed Web of Science ®Google Scholar
• Reardon MJ , Van MieghemNM, PopmaJJet al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N. Engl. J. Med., 376(14), 1321–1331 (2017).
   PubMed Web of Science ®Google Scholar
• Smith CR , LeonMB, MackMJet al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N. Engl. J. Med., 364(23), 2187–2198 (2011).
   PubMed Web of Science ®Google Scholar
• Thourani VH , KodaliS, MakkarRRet al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet, 387(10034), 2218–2225 (2016).
   PubMed Web of Science ®Google Scholar
• Grube E , Van MieghemNM, BleizifferSet al. Clinical outcomes with a repositionable self-expanding transcatheter aortic valve prosthesis: the International FORWARD study. J. Am. Coll. Cardiol., 70(7), 845–853 (2017).
   PubMed Web of Science ®Google Scholar
• Mack MJ , LeonMB, ThouraniVHet al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N. Engl. J. Med., 380(18), 1695–1705 (2019).
   PubMed Web of Science ®Google Scholar
• Popma JJ , DeebGM, YakubovSJet al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N. Engl. J. Med., 380(18), 1706–1715 (2019).
   PubMed Web of Science ®Google Scholar
• Serruys PW , ModoloR, ReardonMet al. One-year outcomes of patients with severe aortic stenosis and an STS PROM of less than three percent in the SURTAVI trial. EuroIntervention, 14(8), 877–883 (2018).
   PubMed Web of Science ®Google Scholar
• Thyregod HG , SteinbruchelDA, IhlemannNet al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the All-Comers NOTION randomized clinical trial. J. Am. Coll. Cardiol., 65(20), 2184–2194 (2015).
   PubMed Web of Science ®Google Scholar
• O’sullivan CJ , WenaweserP. A glimpse into the future: in 2020, which patients will undergo TAVI or SAVR?Interv. Cardiol., 12(1), 44–50 (2017).
   PubMedGoogle Scholar
• Cribier AG . The Odyssey of TAVR from concept to clinical reality. Tex. Heart Inst. J., 41(2), 125–130 (2014).
   PubMed Web of Science ®Google Scholar
• Bourantas CV , SerruysPW. Evolution of transcatheter aortic valve replacement. Circ. Res., 114(6), 1037–1051 (2014).
   PubMed Web of Science ®Google Scholar
• Pilgrim T , LeeJK, O’sullivanCJet al. Early versus newer generation devices for transcatheter aortic valve implantation in routine clinical practice: a propensity score matched analysis. Open Heart, 5(1), e000695 (2018).
   PubMedGoogle Scholar
• Stundl A , LuchtH, ShamekhiJet al. Early versus newer generation transcatheter heart valves for transcatheter aortic valve implantation: echocardiographic and hemodynamic evaluation of an all-comers study cohort using the dimensionless aortic regurgitation index (AR-index). PLoS ONE, 14(5), e0217544 (2019).
   PubMed Web of Science ®Google Scholar
• Yoon S-H , LefèvreT, AhnJ-Met al. Transcatheter aortic valve replacement with early-and new-generation devices in bicuspid aortic valve stenosis. J. Am. Coll. Cardiol., 68(11), 1195–1205 (2016).
   PubMed Web of Science ®Google Scholar
• Didier T , NicolasMVM. New-generation TAVI devices: description and specifications. EuroIntervention, 10, U90–U100 (2014).
   PubMedGoogle Scholar
• Zhang BL , BiancoRW, SchoenFJ. Preclinical assessment of cardiac valve substitutes: current status and considerations for engineered tissue heart valves. Front. Cardiovasc. Med., 6, 72 (2019).
   PubMed Web of Science ®Google Scholar
• Buszman P , MilewskiK, CeballosCFet al. TCT-482 temporal evaluation of a biological response and functionality of a novel, balloon expandable transcatheter aortic valve system (MyVal) in a model of aortic banding. J. Am. Coll. Cardiol., 74(Suppl. 13), B477 (2019).
   PubMed Web of Science ®Google Scholar
• Rao R . The feasibility and safety of a balloon-expandable transcatheter heart valve: MyVal-1 study. London, UK, Oral Abstract.17–19 (2019).
   Google Scholar